Linked Life Data

1750049

Source:http://linkedlifedata.com/resource/pubmed/id/1750049

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1750049rdf:typepubmed:Citationlld:pubmed
pubmed-article:1750049lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:1750049lifeskim:mentionsumls-concept:C0004811lld:lifeskim
pubmed-article:1750049lifeskim:mentionsumls-concept:C0265110lld:lifeskim
pubmed-article:1750049lifeskim:mentionsumls-concept:C0075753lld:lifeskim
pubmed-article:1750049lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:1750049pubmed:issue11lld:pubmed
pubmed-article:1750049pubmed:dateCreated1992-1-22lld:pubmed
pubmed-article:1750049pubmed:abstractTextExperiments were carried out in rabbits to determine whether clentiazem (8-chlorodiltiazem), a cerebrovascular-selective calcium channel blocker, administered 24 hours before subarachnoid hemorrhage influenced the subsequent cerebral vasospasm.lld:pubmed
pubmed-article:1750049pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:languageenglld:pubmed
pubmed-article:1750049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:citationSubsetIMlld:pubmed
pubmed-article:1750049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1750049pubmed:statusMEDLINElld:pubmed
pubmed-article:1750049pubmed:monthNovlld:pubmed
pubmed-article:1750049pubmed:issn0039-2499lld:pubmed
pubmed-article:1750049pubmed:authorpubmed-author:BevanJ AJAlld:pubmed
pubmed-article:1750049pubmed:authorpubmed-author:BevanR DRDlld:pubmed
pubmed-article:1750049pubmed:authorpubmed-author:VorkapicPPlld:pubmed
pubmed-article:1750049pubmed:issnTypePrintlld:pubmed
pubmed-article:1750049pubmed:volume22lld:pubmed
pubmed-article:1750049pubmed:ownerNLMlld:pubmed
pubmed-article:1750049pubmed:authorsCompleteYlld:pubmed
pubmed-article:1750049pubmed:pagination1409-13lld:pubmed
pubmed-article:1750049pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:meshHeadingpubmed-meshheading:1750049-...lld:pubmed
pubmed-article:1750049pubmed:year1991lld:pubmed
pubmed-article:1750049pubmed:articleTitleClentiazem protects against chronic cerebral vasospasm in rabbit basilar artery.lld:pubmed
pubmed-article:1750049pubmed:affiliationDepartment of Pharmacology, College of Medicine, University of Vermont, Burlington 05405.lld:pubmed
pubmed-article:1750049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1750049pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1750049pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed